Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.
FDA inspection history in Hangzhou, China, 2017 to 2018
- 2
- Close-outs
- 1
- Warning letter
Every document, by year
- Close-out
- Warning letter
2017: one warning letter; 2018: two close-out letters.
The story so far
Built from the dates and citations on the documents themselves.
- 2017–18Two close-out letters and one warning letter, at Hangzhou, China.
The complete Teva Pharmaceutical and Chemical (Hangzhou) Co. file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
$297
The price of the documents, added to your cart together
Sites
Hangzhou, China
Two close-out letters and one warning letter · 2017 to 2018
Latest: Close-out, Apr 25, 2018 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2018-04-25 | Close-out Close-out letter | Hangzhou, China | — | $99 |
| 2018-04-25 | Close-out Close-out letter | Hangzhou, China | — | $99 |
| 2017-04-05 | Warning letter Warning letter | Hangzhou, China | — | $99 |
FEI number 3009271645 · most recent document Apr 25, 2018
About Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.
Has Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.; the most recent is dated Apr 5, 2017.